Repro Med Systems (KRMD) Tops Q3 EPS by 3c, provides guidance

Repro Med Systems (NASDAQ: KRMD) reported Q3 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.68 million.

GUIDANCE:

Repro Med Systems sees FY 2024 revenue of $32.75-33.25 million, versus the consensus of $32.172 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• UBS says bull market has further to run